Literature DB >> 10472338

Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC).

N M Malara1, A Sgambato, P Granone, G Flamini, S Margaritora, A Boninsegna, A Cesario, D Galetta, Q Yang, A Cittadini.   

Abstract

BACKGROUND: Non Small Cell Lung Carcinomas (NSCLC) comprise 90% of all lung carcinomas. Studies have demonstrated a preferential central (bronchus-derived) localization for squamous cells, whereas adenocarcinomas are frequently peripheral (bronchiolo-alveolus derived). It has been suggested that exposure to carcinogenic insults including cigarette smoke, may induce different types of tumors in different locations.
MATERIALS AND METHODS: Forty one NSCLC patients staged according to WHO and TNM were considered for localization and biological parameters (p53 expression, cell ploidy and S-phase).
RESULTS: p53 overexpression was found more frequently in central than in peripheral tumors (69% vs 39%) (p = 0.074). Central tumors were more aneuploid (69%) than peripheral ones (46%) (p = 0.03) No difference in smoking habit was observed in the two groups.
CONCLUSIONS: Our results suggest that there is no apparent biological difference between these two groups of NSCLCs, and that the smoking does not play a role in either histotype determination or biological behavior.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472338

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Evaluation of T factor, surgical method, and prognostic factors in central type lung cancer.

Authors:  Makoto Saito; Kinya Furukawa; Toyoaki Miura; Harubumi Kato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-10

2.  Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.

Authors:  Natalia Malara; Valentina Trunzo; Umberto Foresta; Nicola Amodio; Stefania De Vitis; Laura Roveda; Mariagiovanna Fava; MariaLaura Coluccio; Roberta Macrì; Anna Di Vito; Nicola Costa; Chiara Mignogna; Domenico Britti; Ernesto Palma; Vincenzo Mollace
Journal:  J Transl Med       Date:  2016-05-12       Impact factor: 5.531

3.  Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.

Authors:  Q Xue; T Sano; K Kashiwabara; T Oyama; T Nakajima
Journal:  Jpn J Cancer Res       Date:  2001-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.